Latest News
3 Stocks Came Roaring Back—Now They're Flashing Warning Signs
Markets have been on a wild ride this summer, with the S&P 500 finally making a new all-time high and several left-for-dead stocks showing new life in the second half of the year. But not all rallies
HYDB: Systematic High-Yield Bond ETF, Solid Strategy, Track Record, Dividend Yield
HYDB is a high-yield corporate bond index ETF. Its index is quite unique, focusing on high-yield bonds with above-average spreads for their credit quality. HYDB's strategy results in slightly higher d
Canada vows ‘dollar for dollar' response as US puts 50% tariffs on some goods
Collapse of trade talks could lead to job losses, but biggest impact on traditional allies is expected to be political
StubHub: Still A Buy, Still Strong, Still Underrated
StubHub Holdings remains a strong buy at current levels, trading at just 8-9x forward FCF with a solid industry moat. STUB's Q2 2026 results showed 33% GMS growth, $106M adjusted EBITDA, and net lever
Madison Air Solutions to Buy ebm-papst in $5.8B Deal, Expanding Global Airflow Reach
Madison Air Solutions NYSE: MAIR said it has signed an agreement to acquire ebm-papst, a Germany-based provider of high-performance airflow technology, in a transaction valued at $5.8 billion in total
CoreWeave's Economics Are Finally Starting To Work
CoreWeave's revenue surged 112% to $2.6 billion as backlog reached $104 billion and active power expanded to 1.5 GW. New contracts carry 5–10 percentage points higher margins, while CoreWeave raised G
Tesla feature at the center of nearly 3 million-vehicle recall
The US automaker said the recall covers imported and China-made Model 3, Model Y, Model S and Model X vehicles, according to notices filed with China's State Administration for Market Regulation.
Tempus AI: Winning With Precision Medicine
Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine. Recent cancer vaccine developments from Merck and Moderna reinforce the st
U.S.-Canada trade talks collapse, ushering in wave of new tariffs
The U.S. and Canada failed to reach a trade deal on Friday to stave off new tariffs by the Trump administration. The tariffs impact roughly $20 billion worth of Canadian imports, including wine, furni
Nvidia: It's All About SpaceX Now
Nvidia Corporation is undervalued ahead of Q2 FY27 earnings, with market anxiety overblown and consensus estimates overly conservative. The exclusive SpaceX partnership, targeting a 10 GW data center
Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
NEW YORK, Aug. 22, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TB
AST SpaceMobile: Sovereign Satellite Strategy Wins More Contracts; Launch Risks Explored
The $1.3B contracted backlog lowers AST SpaceMobile's EV/Sales to 15.93x, aided by the recent meltdown, the recurring long-term contracts, and the triple-digit growth prospects. They leverage wholesal
WSE Investors Have Opportunity to Lead Wise Group plc Securities Fraud Lawsuit Filed by The Rosen Law Firm
NEW YORK, Aug. 22, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Wise Group plc (NASDAQ: WSE) between May 11, 2026 and July 23, 2026, both
3 Beaten-Down Stocks That Haven't Gotten the Message About the S&P 500's Record Run
Despite many warning signs to the contrary, the S&P 500 continues to climb to fresh record high levels. The latest earnings season showed remarkably resilient performance for many standout companies,
Docusign: The Market Hasn't Caught Up To The Multiple Yet
Docusign remains undervalued, trading at a 14x forward P/E versus peers at 23x, despite a recent 13% stock decline. I maintain a Buy rating, as DOCU's fundamentals have improved while its valuation di
U.S. Steel Stocks Nucor, Steel Dynamics: Big Winners As Canada Trade Talks Collapse?
Nucor and Steel Dynamics tumbled last week on the prospect of lower steel tariffs.
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
Shares of TG Therapeutics rose this week after buyout rumors surfaced. TG is a prime takeover target, fueled by Briumvi's growth and recent subcutaneous formulation de-risking. I see a potential acqui
Morgan Stanley Direct Lending Fund: The Dividend Is Likely To Get Slashed (Rating Downgrade)
I'm downgrading the Morgan Stanley Direct Lending Fund to a "Sell" due to rising non-accruals and deteriorating fundamentals. Q2 saw NII per share fall to $0.55 and non-accruals spike from 1.5% to 2.9
PLAB DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Photronics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 4 Deadline in Securities Class Action - PLAB
New York, New York--(Newsfile Corp. - August 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Photronics, Inc. (NASDAQ: PLAB) between December 10
SMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit
NEW YORK, Aug. 22, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of The Simply Good Foods Company (NA